Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines.

Karagiannis ED, Popel AS.

J Cell Biochem. 2008 Jul 1;104(4):1356-63. doi: 10.1002/jcb.21712.

PMID:
18307172
2.

CXC chemokines in angiogenesis.

Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM.

J Leukoc Biol. 2000 Jul;68(1):1-8. Review.

PMID:
10914483
3.

CXC chemokines in angiogenesis relevant to chronic fibroproliferation.

Strieter RM, Belperio JA, Burdick MD, Keane MP.

Curr Drug Targets Inflamm Allergy. 2005 Feb;4(1):23-6. Review.

PMID:
15720231
4.

The role of CXC chemokines as regulators of angiogenesis.

Strieter RM, Polverini PJ, Arenberg DA, Kunkel SL.

Shock. 1995 Sep;4(3):155-60. Review.

PMID:
8574748
5.

The role of CXC chemokines and their receptors in cancer.

Vandercappellen J, Van Damme J, Struyf S.

Cancer Lett. 2008 Aug 28;267(2):226-44. doi: 10.1016/j.canlet.2008.04.050. Review.

PMID:
18579287
6.

CXC chemokines in angiogenesis.

Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP.

Cytokine Growth Factor Rev. 2005 Dec;16(6):593-609. Review.

PMID:
16046180
7.

Cancer CXC chemokine networks and tumour angiogenesis.

Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA.

Eur J Cancer. 2006 Apr;42(6):768-78. Review.

PMID:
16510280
8.

CXC chemokines in angiogenesis of cancer.

Strieter RM, Belperio JA, Phillips RJ, Keane MP.

Semin Cancer Biol. 2004 Jun;14(3):195-200. Review.

PMID:
15246055
9.

Understanding the immunoangiostatic CXC chemokine network.

Balestrieri ML, Balestrieri A, Mancini FP, Napoli C.

Cardiovasc Res. 2008 May 1;78(2):250-6. doi: 10.1093/cvr/cvn029. Review.

PMID:
18252760
10.

ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.

Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M.

Pharmacol Ther. 2006 Oct;112(1):139-49. Review.

PMID:
16720046
11.

CD36-TSP-HRGP interactions in the regulation of angiogenesis.

Silverstein RL, Febbraio M.

Curr Pharm Des. 2007;13(35):3559-67. Review.

PMID:
18220792
12.

Discovery and development of anti-angiogenic peptides: A structural link.

Dings RP, Nesmelova I, Griffioen AW, Mayo KH.

Angiogenesis. 2003;6(2):83-91. Review.

PMID:
14739615
13.

CXC chemokines and angiogenesis/angiostasis.

Keane MP, Arenberg DA, Moore BB, Addison CL, Strieter RM.

Proc Assoc Am Physicians. 1998 Jul-Aug;110(4):288-96. Review.

PMID:
9686676
14.

Inhibition of angiogenesis by cleaved high molecular weight kininogen (HKa) and HKa domain 5.

McCrae KR, DoƱate F, Merkulov S, Sun D, Qi X, Shaw DE.

Curr Cancer Drug Targets. 2005 Nov;5(7):519-28. Review.

PMID:
16305348
15.

Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent.

Wang JB, Wang MD, Li EX, Dong DF.

Peptides. 2012 Dec;38(2):457-62. doi: 10.1016/j.peptides.2012.09.007. Review.

PMID:
22985857
16.

CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer.

Strieter RM, Belperio JA, Burdick MD, Sharma S, Dubinett SM, Keane MP.

Ann N Y Acad Sci. 2004 Dec;1028:351-60. Review.

PMID:
15650260
17.

The interleukin-8 pathway in cancer.

Waugh DJ, Wilson C.

Clin Cancer Res. 2008 Nov 1;14(21):6735-41. doi: 10.1158/1078-0432.CCR-07-4843. Review.

18.

The emerging role of CXC chemokines in epithelial ovarian cancer.

Rainczuk A, Rao J, Gathercole J, Stephens AN.

Reproduction. 2012 Sep;144(3):303-17. doi: 10.1530/REP-12-0153. Review.

19.

Roles of platelet factor 4 in hematopoiesis and angiogenesis.

Maurer AM, Zhou B, Han ZC.

Growth Factors. 2006 Dec;24(4):242-52. Review.

PMID:
17381065
20.

Chemokines as mediators of neovascularization.

Keeley EC, Mehrad B, Strieter RM.

Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1928-36. doi: 10.1161/ATVBAHA.108.162925. Review.

Supplemental Content

Support Center